663 related articles for article (PubMed ID: 16287955)
21. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
[TBL] [Abstract][Full Text] [Related]
22. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
Hess CN; Lopes RD; Gibson CM; Hager R; Wojdyla DM; Englum BR; Mack MJ; Califf RM; Kouchoukos NT; Peterson ED; Alexander JH
Circulation; 2014 Oct; 130(17):1445-51. PubMed ID: 25261549
[TBL] [Abstract][Full Text] [Related]
23. Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709).
Kulik A; Abreu AM; Boronat V; Ruel M
Contemp Clin Trials; 2017 Aug; 59():98-104. PubMed ID: 28611006
[TBL] [Abstract][Full Text] [Related]
24. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
[TBL] [Abstract][Full Text] [Related]
25. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).
Yau JM; Alexander JH; Hafley G; Mahaffey KW; Mack MJ; Kouchoukos N; Goyal A; Peterson ED; Gibson CM; Califf RM; Harrington RA; Ferguson TB;
Am J Cardiol; 2008 Sep; 102(5):546-51. PubMed ID: 18721510
[TBL] [Abstract][Full Text] [Related]
26. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
Olenchock SA; Karmpaliotis D; Gibson WJ; Murphy SA; Southard MC; Ciaglo L; Buros J; Mack MJ; Alexander JH; Harrington RA; Califf RM; Kouchoukos NT; Ferguson TB; Gibson CM
Ann Thorac Surg; 2008 Feb; 85(2):520-4. PubMed ID: 18222256
[TBL] [Abstract][Full Text] [Related]
27. Early quantitative coronary angiography of saphenous vein grafts for coronary artery bypass grafting harvested by means of open versus endoscopic saphenectomy: a prospective randomized trial.
Perrault LP; Jeanmart H; Bilodeau L; Lespérance J; Tanguay JF; Bouchard D; Pagé P; Carrier M
J Thorac Cardiovasc Surg; 2004 May; 127(5):1402-7. PubMed ID: 15115999
[TBL] [Abstract][Full Text] [Related]
28. Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.
Mehta RH; Ferguson TB; Lopes RD; Hafley GE; Mack MJ; Kouchoukos NT; Gibson CM; Harrington RA; Califf RM; Peterson ED; Alexander JH;
Circulation; 2011 Jul; 124(3):280-8. PubMed ID: 21709060
[TBL] [Abstract][Full Text] [Related]
29. The Graft Imaging to Improve Patency (GRIIP) clinical trial results.
Singh SK; Desai ND; Chikazawa G; Tsuneyoshi H; Vincent J; Zagorski BM; Pen V; Moussa F; Cohen GN; Christakis GT; Fremes SE
J Thorac Cardiovasc Surg; 2010 Feb; 139(2):294-301, 301.e1. PubMed ID: 20006356
[TBL] [Abstract][Full Text] [Related]
30. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.
Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
Circulation; 1994 Mar; 89(3):1138-43. PubMed ID: 8124800
[TBL] [Abstract][Full Text] [Related]
31. Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.
Taggart DP; Webb CM; Desouza A; Yadav R; Channon KM; De Robertis F; Di Mario C
J Cardiothorac Surg; 2018 Nov; 13(1):117. PubMed ID: 30453984
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of the Logistic Clinical Syntax Score in Prediction of Saphenous Vein Graft Failure in Patients Undergoing Coronary Artery Bypass Grafting.
Ozturk D; Celık O; Cakmak HA; Akın F; Aslan S; Enhos A; Tasbulak O; Ayca B; Erkanlı K; Bakır İ
Angiology; 2015 Sep; 66(8):714-20. PubMed ID: 25385816
[TBL] [Abstract][Full Text] [Related]
33. No-touch saphenous vein grafts in coronary artery surgery (SWEDEGRAFT): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial.
Ragnarsson S; Janiec M; Modrau IS; Dreifaldt M; Ericsson A; Holmgren A; Hultkvist H; Jeppsson A; Sartipy U; Ternström L; Per Vikholm MD; de Souza D; James S; Thelin S
Am Heart J; 2020 Jun; 224():17-24. PubMed ID: 32272256
[TBL] [Abstract][Full Text] [Related]
34. Rationale and design of a single-center randomized trial to compare the graft patency between the radial artery and the no-touch saphenous vein in coronary artery bypass grafting surgery (GRAFT-CAB Study).
Zhang F; Tian M; Wang X; Zhang H; Zhou X; Liu R; Liu R; Jin Z; Zhang C; Wang X
Am Heart J; 2024 Aug; 274():46-53. PubMed ID: 38710379
[TBL] [Abstract][Full Text] [Related]
35. Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study.
Johansson BL; Souza DS; Bodin L; Filbey D; Loesch A; Geijer H; Bojö L
Eur J Cardiothorac Surg; 2010 Oct; 38(4):414-9. PubMed ID: 20362457
[TBL] [Abstract][Full Text] [Related]
36. Off-Pump coronary artery bypass surgery is associated with worse arterial and saphenous vein graft patency and less effective revascularization: Results from the Veterans Affairs Randomized On/Off Bypass (ROOBY) trial.
Hattler B; Messenger JC; Shroyer AL; Collins JF; Haugen SJ; Garcia JA; Baltz JH; Cleveland JC; Novitzky D; Grover FL;
Circulation; 2012 Jun; 125(23):2827-35. PubMed ID: 22592900
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of hormone therapy in women after coronary bypass surgery. Evidence of differential effect of hormone therapy on angiographic progression of disease in saphenous vein grafts and native coronary arteries.
Ouyang P; Tardif JC; Herrington DM; Stewart KJ; Thompson PD; Walsh MN; Bennett SK; Heldman AW; Tayback MA; Wang NY;
Atherosclerosis; 2006 Dec; 189(2):375-86. PubMed ID: 16442114
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
Sun JC; Teoh KH; Lamy A; Sheth T; Ellins ML; Jung H; Yusuf S; Anand S; Connolly S; Whitlock RP; Eikelboom JW
Am Heart J; 2010 Dec; 160(6):1178-84. PubMed ID: 21146675
[TBL] [Abstract][Full Text] [Related]
39. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.
Arvela E; Venermo M; Söderström M; Albäck A; Lepäntalo M
Ann Vasc Surg; 2012 Apr; 26(3):396-403. PubMed ID: 22285375
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy and vein graft patency in coronary artery bypass graft surgery.
Conti VR; Hunter GC
JAMA; 2005 Nov; 294(19):2495-7. PubMed ID: 16287962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
